Filament’s AbbVie ABBV Stock Holding History

Filament’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-5,300	Closed	-$303K	–	32
2016 Q1	$303K	Sell	5,300 -550	-9%	-$30.7K	0.14%	40
2015 Q4	$347K	Buy	+5,850	New	+$337K	0.17%	41

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Filament's ABBV Position: Q2 2016 in Review

Filament sold out of AbbVie (ABBV) in Q2 2016, closing a stake of 5,300 shares — an estimated $303K sold.

Filament first reported a position in ABBV in Q4 2015 and held it in 2 quarters. The position peaked at $347K in Q4 2015. 1,634 funds tracked by Wall St. Rank hold ABBV as of Q2 2016.

Filament reported no remaining AbbVie position as of Q2 2016 after selling out during the quarter.
Filament sold 5,300 AbbVie shares in Q2 2016, an estimated $303K.
Filament first reported a position in AbbVie in Q4 2015 and held it in 2 quarters.
Filament's AbbVie position peaked at $347K in Q4 2015.
1,634 funds tracked by Wall St. Rank held AbbVie as of Q2 2016.

Based on Filament's 13F filing for Q2 2016, filed 28 Jul 2016.